AACE Clinical Case Reports (Jan 2021)

COVID-19 Presenting With Diabetic Ketoacidosis: A Case Series

  • Ramya S. Gorthi, MD,
  • Ghassan Kamel, MD,
  • Sandeep Dhindsa, MD,
  • Ravi P. Nayak, MD, FCCP

Journal volume & issue
Vol. 7, no. 1
pp. 6 – 9

Abstract

Read online

Objective: Diabetes mellitus has been recognized as one of the comorbidities that predict the severity of illness in patients infected with COVID-19. The characteristics of patients presenting with diabetic ketoacidosis (DKA) and COVID-19 infection have not been described. Methods: We describe 5 patients with DKA and concomitant COVID-19 admitted to the intensive care unit of an academic medical center. Three patients had type 1 diabetes mellitus, and 2 patients had type 2 diabetes mellitus. Results: While DKA with an infectious etiology is a common presentation, we observed that the patients with DKA precipitated by COVID-19 presented with atypical symptoms. COVID-19 infection was revealed during search for an etiology of DKA. Conclusion: It is prudent to have a low threshold to screen for COVID-19 infection in patients with DKA.

Keywords